ArticleJournal of the American Heart Association2019

Comparisons of Rivaroxaban Following Different Dosage Criteria (ROCKET AF or J-ROCKET AF Trials) in Asian Patients With Atrial Fibrillation.

Yi-Hsin Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.